Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance.

Flores A, Argetsinger LS, Stadler LKJ, Malaga AE, Vander PB, DeSantis LC, Joe RM, Cline JM, Keogh JM, Henning E, Barroso I, Mendes de Oliveira E, Chandrashekar G, Clutter ES, Hu Y, Stuckey J, Farooqi IS, Myers MG Jr, Carter-Su C.

Diabetes. 2019 Aug 22. pii: db190608. doi: 10.2337/db19-0608. [Epub ahead of print]

PMID:
31439647
2.

Phosphorylation of the Unique C-Terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α To Enhance Nerve Growth Factor Function.

Joe RM, Flores A, Doche ME, Cline JM, Clutter ES, Vander PB, Riedel H, Argetsinger LS, Carter-Su C.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00277-17. doi: 10.1128/MCB.00277-17. Print 2018 Mar 15.

3.

The Dyslexia-susceptibility Protein KIAA0319 Inhibits Axon Growth Through Smad2 Signaling.

Franquinho F, Nogueira-Rodrigues J, Duarte JM, Esteves SS, Carter-Su C, Monaco AP, Molnár Z, Velayos-Baeza A, Brites P, Sousa MM.

Cereb Cortex. 2017 Mar 1;27(3):1732-1747. doi: 10.1093/cercor/bhx023.

4.

Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis.

Xue X, Ramakrishnan SK, Weisz K, Triner D, Xie L, Attili D, Pant A, Győrffy B, Zhan M, Carter-Su C, Hardiman KM, Wang TD, Dame MK, Varani J, Brenner D, Fearon ER, Shah YM.

Cell Metab. 2016 Sep 13;24(3):447-461. doi: 10.1016/j.cmet.2016.07.015. Epub 2016 Aug 18.

5.

Growth hormone signaling pathways.

Carter-Su C, Schwartz J, Argetsinger LS.

Growth Horm IGF Res. 2016 Jun;28:11-5. doi: 10.1016/j.ghir.2015.09.002. Epub 2015 Sep 10.

PMID:
26421979
6.

Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1.

Pearce LR, Joe R, Doche ME, Su HW, Keogh JM, Henning E, Argetsinger LS, Bochukova EG, Cline JM, Garg S, Saeed S, Shoelson S, O'Rahilly S, Barroso I, Rui L, Farooqi IS, Carter-Su C.

Endocrinology. 2014 Sep;155(9):3219-26. doi: 10.1210/en.2014-1264. Epub 2014 Jun 27.

7.

Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele.

Anderson NM, Javadi M, Berndl E, Berberovic Z, Bailey ML, Huang K, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Carter-Su C, Wang C, McNagny KM, Paulson RF, Minden MD, Stanford WL, Barber DL.

PLoS One. 2013 Sep 25;8(9):e75472. doi: 10.1371/journal.pone.0075472. eCollection 2013.

9.

Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.

O'Leary EE, Mazurkiewicz-Muñoz AM, Argetsinger LS, Maures TJ, Huynh HT, Carter-Su C.

Mol Endocrinol. 2013 Apr;27(4):619-34. doi: 10.1210/me.2011-1275. Epub 2013 Feb 28.

10.

Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.

Su HW, Lanning NJ, Morris DL, Argetsinger LS, Lumeng CN, Carter-Su C.

J Cell Sci. 2013 Apr 15;126(Pt 8):1733-43. doi: 10.1242/jcs.113050. Epub 2013 Feb 26.

11.

Human SH2B1 mutations are associated with maladaptive behaviors and obesity.

Doche ME, Bochukova EG, Su HW, Pearce LR, Keogh JM, Henning E, Cline JM, Saeed S, Dale A, Cheetham T, Barroso I, Argetsinger LS, O'Rahilly S, Rui L, Carter-Su C, Farooqi IS.

J Clin Invest. 2012 Dec;122(12):4732-6. doi: 10.1172/JCI62696. Epub 2012 Nov 19. Erratum in: J Clin Invest. 2013 Jan 2;123(1):526. Saeed, Sadia [added].

12.

The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Javadi M, Hofstätter E, Stickle N, Beattie BK, Jaster R, Carter-Su C, Barber DL.

J Biol Chem. 2012 Jul 27;287(31):26223-34. doi: 10.1074/jbc.M112.382721. Epub 2012 Jun 5.

13.

Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.

Ray BN, Kweon HK, Argetsinger LS, Fingar DC, Andrews PC, Carter-Su C.

Mol Endocrinol. 2012 Jun;26(6):1056-73. doi: 10.1210/me.2011-1258. Epub 2012 May 8.

14.

Glucose enhances leptin signaling through modulation of AMPK activity.

Su H, Jiang L, Carter-Su C, Rui L.

PLoS One. 2012;7(2):e31636. doi: 10.1371/journal.pone.0031636. Epub 2012 Feb 16.

15.

Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number.

Lanning NJ, Su HW, Argetsinger LS, Carter-Su C.

J Cell Sci. 2011 Sep 15;124(Pt 18):3095-105. doi: 10.1242/jcs.081547. Epub 2011 Aug 30.

16.

JAKs, Stats, and CK2?

Carter-Su C, Argetsinger LS.

Blood. 2011 Jul 7;118(1):5-6. doi: 10.1182/blood-2011-05-352542. No abstract available.

17.

Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1β to regulate its cellular function and distribution.

Maures TJ, Su HW, Argetsinger LS, Grinstein S, Carter-Su C.

J Cell Sci. 2011 May 1;124(Pt 9):1542-52. doi: 10.1242/jcs.078949. Epub 2011 Apr 12.

18.

C/EBPβ mediates growth hormone-regulated expression of multiple target genes.

Cui TX, Lin G, LaPensee CR, Calinescu AA, Rathore M, Streeter C, Piwien-Pilipuk G, Lanning N, Jin H, Carter-Su C, Qin ZS, Schwartz J.

Mol Endocrinol. 2011 Apr;25(4):681-93. doi: 10.1210/me.2010-0232. Epub 2011 Feb 3.

19.

Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity.

Argetsinger LS, Stuckey JA, Robertson SA, Koleva RI, Cline JM, Marto JA, Myers MG Jr, Carter-Su C.

Mol Endocrinol. 2010 May;24(5):1062-76. doi: 10.1210/me.2009-0355. Epub 2010 Mar 19.

21.

Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling.

Robertson SA, Koleva RI, Argetsinger LS, Carter-Su C, Marto JA, Feener EP, Myers MG Jr.

Mol Cell Biol. 2009 Jun;29(12):3367-78. doi: 10.1128/MCB.00278-09. Epub 2009 Apr 13.

22.

Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling.

Thompson BR, Mazurkiewicz-Muñoz AM, Suttles J, Carter-Su C, Bernlohr DA.

J Biol Chem. 2009 May 15;284(20):13473-80. doi: 10.1074/jbc.M900075200. Epub 2009 Mar 23.

23.

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.

Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C, Argetsinger LS, Rastaldi MP, Brosius FC, Kretzler M.

Diabetes. 2009 Feb;58(2):469-77. doi: 10.2337/db08-1328. Epub 2008 Nov 18.

24.

JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Jin H, Lanning NJ, Carter-Su C.

Mol Endocrinol. 2008 Aug;22(8):1825-41. doi: 10.1210/me.2008-0015. Epub 2008 May 22.

26.

SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms.

Li Z, Zhou Y, Carter-Su C, Myers MG Jr, Rui L.

Mol Endocrinol. 2007 Sep;21(9):2270-81. Epub 2007 Jun 12.

PMID:
17565041
27.

Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion.

Diakonova M, Helfer E, Seveau S, Swanson JA, Kocks C, Rui L, Carlier MF, Carter-Su C.

Infect Immun. 2007 Jul;75(7):3581-93. Epub 2007 Apr 23.

28.

Recent advances in growth hormone signaling.

Lanning NJ, Carter-Su C.

Rev Endocr Metab Disord. 2006 Dec;7(4):225-35. Review.

PMID:
17308965
29.

Multiplexed detection of protein-peptide interaction and inhibition using capillary electrophoresis.

Yang P, Whelan RJ, Mao Y, Lee AW, Carter-Su C, Kennedy RT.

Anal Chem. 2007 Feb 15;79(4):1690-5.

PMID:
17297974
30.

SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other.

Maures TJ, Kurzer JH, Carter-Su C.

Trends Endocrinol Metab. 2007 Jan-Feb;18(1):38-45. Epub 2006 Nov 30. Review.

PMID:
17140804
31.

Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.

Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C.

Mol Cell Biol. 2006 Sep;26(17):6381-94.

32.

Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.

Mazurkiewicz-Munoz AM, Argetsinger LS, Kouadio JL, Stensballe A, Jensen ON, Cline JM, Carter-Su C.

Mol Cell Biol. 2006 Jun;26(11):4052-62.

33.

Mentoring for success in physiology. Bodil M. Schmidt Nielsen Award presentation.

Carter-Su C.

Physiologist. 2005 Aug;48(4):167, 172-8. No abstract available.

PMID:
16184777
34.

Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bbeta as a model system.

Yang P, Whelan RJ, Jameson EE, Kurzer JH, Argetsinger LS, Carter-Su C, Kabir A, Malik A, Kennedy RT.

Anal Chem. 2005 Apr 15;77(8):2482-9.

PMID:
15828784
35.

Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C.

Mol Cell Biol. 2004 Jun;24(11):4955-67.

36.

Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.

Kurzer JH, Argetsinger LS, Zhou YJ, Kouadio JL, O'Shea JJ, Carter-Su C.

Mol Cell Biol. 2004 May;24(10):4557-70.

38.

CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes.

Tang H, Macpherson P, Argetsinger LS, Cieslak D, Suhr ST, Carter-Su C, Goldman D.

Cell Signal. 2004 May;16(5):551-63.

PMID:
14751541
39.

SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells.

Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C.

J Biol Chem. 2004 Jan 2;279(1):133-41. Epub 2003 Oct 16.

40.

YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.

O'Brien KB, Argetsinger LS, Diakonova M, Carter-Su C.

J Biol Chem. 2003 Apr 4;278(14):11970-8. Epub 2003 Jan 27.

41.

SH2-Bbeta is a Rac-binding protein that regulates cell motility.

Diakonova M, Gunter DR, Herrington J, Carter-Su C.

J Biol Chem. 2002 Mar 22;277(12):10669-77. Epub 2002 Jan 10.

42.

SH2-B family members differentially regulate JAK family tyrosine kinases.

O'Brien KB, O'Shea JJ, Carter-Su C.

J Biol Chem. 2002 Mar 8;277(10):8673-81. Epub 2001 Dec 18.

43.

Signaling pathways activated by the growth hormone receptor.

Herrington J, Carter-Su C.

Trends Endocrinol Metab. 2001 Aug;12(6):252-7. Review.

PMID:
11445442
44.

SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.

Carter-Su C, Rui L, Stofega MR.

Recent Prog Horm Res. 2000;55:293-311. Review.

PMID:
11036942
45.
46.

Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.

Carter-Su C, Rui L, Herrington J.

Pediatr Nephrol. 2000 Jul;14(7):550-7. Review.

47.

The role of STAT proteins in growth hormone signaling.

Herrington J, Smit LS, Schwartz J, Carter-Su C.

Oncogene. 2000 May 15;19(21):2585-97. Review.

48.

Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.

Stofega MR, Argetsinger LS, Wang H, Ullrich A, Carter-Su C.

J Biol Chem. 2000 Sep 8;275(36):28222-9.

49.

Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.

Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R.

J Biol Chem. 2000 Aug 11;275(32):24935-44.

50.

SH2-B is required for growth hormone-induced actin reorganization.

Herrington J, Diakonova M, Rui L, Gunter DR, Carter-Su C.

J Biol Chem. 2000 Apr 28;275(17):13126-33.

Supplemental Content

Loading ...
Support Center